Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Stroke. 2005;36:2373-2378
Published online before print October 13, 2005, doi: 10.1161/01.STR.0000185922.49809.46
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
36/11/2373    most recent
01.STR.0000185922.49809.46v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spence, J. D.
Right arrow Articles by Ferguson, G. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spence, J. D.
Right arrow Articles by Ferguson, G. G.
Related Collections
Right arrow Carotid Stenosis
Right arrow Doppler ultrasound, Transcranial Doppler etc.
Right arrow Carotid endarterectomy
Right arrow Angioplasty and Stenting

(Stroke. 2005;36:2373.)
© 2005 American Heart Association, Inc.

Original Contributions

Absence of Microemboli on Transcranial Doppler Identifies Low-Risk Patients With Asymptomatic Carotid Stenosis

J. David Spence, MD; Arturo Tamayo, MD; Stephen P. Lownie, MD; Wai P. Ng, MD Gary G. Ferguson, MD, PhD

From the Stroke Prevention & Atherosclerosis Research Centre (J.D.S., A.T.), Robarts Research Institute, and the London Health Sciences Centre (J.D.S., S.P.L., W.P.N., G.G.F.), University of Western Ontario, London, Canada; currently at the University of Manitoba (A.T.), Winnipeg, Canada.

Correspondence to J. David Spence, Stroke Prevention & Atherosclerosis Research Centre, 1400 Western Rd, London, Ontario, Canada N6G 2V2. E-mail dspence{at}robarts.ca

Background and Purpose— Carotid endarterectomy clearly benefits patients with symptomatic severe stenosis (SCS), but the risk of stroke is so low for asymptomatic patients (ACS) that the number needed to treat is very high. We studied transcranial Doppler (TCD) embolus detection as a method for identifying patients at higher risk who would have a lower number needed to treat.

Methods— Patients with carotid stenosis of ≥60% by Doppler ultrasound who had never been symptomatic (81%) or had been asymptomatic for at least 18 months (19%) were studied with TCD embolus detection for up to 1 hour on 2 occasions a week apart; patients were followed for 2 years.

Results— 319 patients were studied, age (standard deviation) 69.68 (9.12) years; 32 (10%) had microemboli at baseline (TCD+). Events were more likely to occur in the first year. Patients with microemboli were much more likely to have microemboli 1 year later (34.4 versus 1.4%; P<0.0001) and were more likely to have a stroke during the first year of follow-up (15.6%, 95% CI, 4.1 to 79; versus 1%, 95% CI, 1.01 to 1.36; P<0.0001).

Conclusions— Our findings indicate that TCD– ACS will not benefit from endarterectomy or stenting unless it can be done with a risk <1%; TCD+ may benefit as much as SCS if their surgical risk is not higher. These findings suggest that ACS should be managed medically with delay of surgery or stenting until the occurrence of symptoms or emboli.


Key Words: asymptomatic carotid stenosis • endarterectomy • transcranial Doppler • ulcer • ultrasound • unstable plaque




This article has been cited by other articles:


Home page
 NeurologyHome page
R. M. Kwee, R. J. van Oostenbrugge, L. Hofstra, G. J. Teule, J.M.A. van Engelshoven, W. H. Mess, and M. E. Kooi
Identifying vulnerable carotid plaques by noninvasive imaging
Neurology, June 10, 2008; 70(24_Part_2): 2401 - 2409.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
J. Golledge, S. Mangan, and P. Clancy
Effects of Peroxisome Proliferator-Activated Receptor Ligands in Modulating Tissue Factor and Tissue Factor Pathway Inhibitor in Acutely Symptomatic Carotid Atheromas
Stroke, May 1, 2007; 38(5): 1501 - 1508.
[Abstract] [Full Text] [PDF]

Home page
 Vasc MedHome page
E. R. Bates, C. J. D. Babb, D. E. Casey, C. U. Cates, G. R. Duckwiler, T. E. Feldman, W. A. Gray, K. Ouriel, E. D. Peterson, K. Rosenfield, et al.
ACCF/SCAI/SVMB/SIR/ASITN 2007 Clinical Expert Consensus Document on Carotid Stenting: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting)
Vascular Medicine, February 1, 2007; 12(1): 35 - 83.
[PDF]

Home page
 StrokeHome page
C. P. Derdeyn
Carotid Stenting for Asymptomatic Carotid Stenosis: Trial It
Stroke, February 1, 2007; 38(2): 715 - 720.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
American Society of Interventional & Therapeutic N, Society for Cardiovascular Angiography and Interve, Society for Vascular Medicine and Biology, Society of Interventional Radiology, E. R. Bates, J. D. Babb, D. E. Casey Jr, C. U. Cates, G. R. Duckwiler, T. E. Feldman, et al.
ACCF/SCAI/SVMB/SIR/ASITN 2007 Clinical Expert Consensus Document on Carotid Stenting: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting)
J. Am. Coll. Cardiol., January 2, 2007; 49(1): 126 - 170.
[Full Text] [PDF]


Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.